I was not sure if this article has been posted here. But just in case:
"TAKE-HOME MESSAGE
The authors compared oncologic outcomes in men with prostate cancer and, at most, five suspicious areas on bone scan, treated either with prostatectomy (n = 38) or androgen-deprivation therapy (ADT; n = 41). Progression-free and cancer-specific survival were markedly better in men treated with prostatectomy vs ADT (75 vs 28 months; endpoint not reached vs 40 months, respectively). Multivariate analysis demonstrated prostatectomy as an independent predictor of these survival outcomes. Additionally, men treated with prostatectomy reported fewer urinary complications.
These results support ongoing efforts to define the role of prostatectomy in oligometastatic disease. Despite limitations of the study, the authors demonstrate that prostatectomy is safe and feasible in carefully selected men with oligometastatic disease.
– Michael H. Johnson, MD"